CSIMarket
 

Masimo Corp  (NASDAQ: MASI)

Masimo's

Competitiveness




 

MASI Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Masimo reported Revenue increase in the 1 quarter 2026 by 8.28 % year on year.
The revenue growth was below Masimo's competitors' average revenue growth of 9.59 %, achieved in the same quarter.

List of MASI Competitors

With a net margin of 14.18 % Masimo achieved higher profitability than its competitors.

More on MASI Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Masimo Corp achieved net profit of $57.10 millions compared to a net loss of $-170.70 millions recorded in the same quarter a year ago.

<<  MASI Stock Performance Comparisons



  

Overall company Market Share Q1 2026

Revenue in Overall company grew by 8.28 %, less than Masimo Corp peers within this division.
<<  More on MASI Market Share.
 
*Market share is calculated based on total revenue.

  News about Masimo Corp Contracts

Masimos Pulse Oximetry Technology Demonstrates Accuracy in Critical Care Across Skin Tones and Market Performance Im...

October 9, 2025
Masimo Corp, a global leader in innovative non-invasive monitoring technologies, has been in the spotlight recently for two reasons: the remarkable performance of its pulse oximetry technology in critical care settings and its improved market performance over the past week. This article provides a examination of these developments, outlining the implications for both the healthcare sector and Masimo s market standing. Innovative Pulse Oximetry Technology In a recent publication in CHEST Critical Care, researchers led by Dr. Andrew Goodwin from the Medical University of South Carolina (MUSC) conducted an exploratory analysis as part of a unique feasibility study. The study sought to evaluate the performance ...

Spanish Hospital Launches Innovative Remote Patient Monitoring Program with Masimos Wearable Medical Devices

June 3, 2024
Germans Trias i Pujol, a cutting-edge hospital serving over 800,000 people north of Barcelona, Spain, has unveiled a groundbreaking telemedicine and remote patient management initiative using Masimo s advanced wearable medical technology. The SESHAT project leverages wearable devices and wireless connectivity, empowering doctors to remotely track patient data and provide personalized care. This article explores the implications of this innovative program and analyzes Masimo s recent financial performance compared to its competitors.The SESHAT Project Revolutionizing Remote Patient Monitoring:The Germans Trias i Pujol hospital has embarked on an exciting journey to revolutionize healthcare delivery through th...

Augmenting Clinical Research: Medable and Masimo Team Up to Bring Cutting-Edge Wea...

May 29, 2024
Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and DataPALO ALTO, Calif. - Medable Inc., the leading technology provider for modern clinical trials, has announced a partnership with industry leader Masimo (NASDAQ: MASI) to introduce the use of high-quality medical-grade wearable devices in clinical research. Masimo s pulse oximeter technology, which has been trusted by clinicians for over 25 years to monitor millions of patients annually, will now enable more patients to participate in clinical trials with reduced burdens.Masimo s pulse oximeter technology has gained widespread recognition among medical professionals for its accuracy and re...

Masimo Corporation Considers Separation of Consumer Business Amidst Revenue Decline and Enhanced Profitability

March 22, 2024
Masimo Corporation, a leading global provider of noninvasive monitoring technologies and audio products, is contemplating the separation of its consumer business. The company s Board of Directors has authorized management to assess the proposed separation, which is expected to encompass consumer audio and health products like the Stork baby monitor and Freedom smartwatch. This strategic move comes as Masimo faces a decline in revenue compared to its competitors. However, the company has managed to achieve higher profitability through its distinct market positioning and innovative product offerings.Examining the Revenue Decline:In the fourth quarter of 2023, Masimo witnessed a year-on-year revenue decrease of...





Publicly Traded Peers of Masimo Corp




Alcon inc
Share Performance



-6.91%
This Year



Alcon inc
Profile

Alcon Inc's business model revolves around providing advanced eye care products and services, including pharmaceuticals, surgical equipment, and vision care solutions.

More about Alcon inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 35,845.488 mill. $ 12,997.000 mill. $ 1,156.000 mill.


Medtronic Plc
Share Performance



+0.17%
Over The Past 5 Days



Medtronic Plc
Profile

Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.

More about Medtronic Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 118,866.110 mill. $ 35,483.000 mill. $ 4,639.000 mill.


Movano Inc
Share Performance



+50.99%
Over The Past 5 Days



Movano Inc
Profile

a Delaware corporation, is developing a platform to deliver purpose-driven healthcare solutions at the intersection of medtech and consumer devices

More about Movano Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 362.912 mill. $ 4.435 mill. $ -27.652 mill.


Non Invasive Monitoring Systems Inc
Share Performance



+19,900.00%
This Quarter



Non Invasive Monitoring Systems Inc
Profile

Non Invasive Monitoring Systems Inc operates by providing non-invasive medical monitoring solutions that utilize advanced technologies to measure various physiological parameters for improved patient care in healthcare settings. Their business model focuses on developing and selling innovative monitoring devices and systems to healthcare professionals and institutions.

More about Non Invasive Monitoring Systems Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 11.359 mill. $ - mill. $ -0.550 mill.


Koninklijke Philips Nv
Share Performance



-2.87%
One Year



Koninklijke Philips Nv
Profile

Koninklijke Philips Nv operates as a diversified technology company, focusing on areas such as healthcare, consumer lifestyle, and lighting. The company provides a wide range of products and solutions, including medical imaging equipment, home appliances, personal care products, and lighting solutions. Philips Nv's business model involves innovation-driven research and development, strategic partnerships, and a global distribution network to deliver its products and services to customers worldwide.

More about Koninklijke Philips Nv's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 19,974.080 mill. $ 1,004.640 mill.

14 more competitors available

Sign in to see all competitors

Sources: Masimo Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Masimo Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.